Revolution Medicines, Inc. Warrant
NASDAQ: RVMDW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mark A. Goldsmith
- Employees
- 616
- Headquarters
- Redwood City, United States
- IPO year
- 2020
- Market cap
- $34.7B
- Website
- https://www.revmed.com
Loading RVMDW…
Loading profile data…Frequently asked questions about RVMDW
What does Revolution Medicines, Inc. Warrant (RVMDW) do?
Revolution Medicines, Inc. is a biopharmaceutical company in the clinical development phase, concentrating on creating innovative, precisely targeted therapies for cancers driven by RAS pathway dysregulation. The firm's drug development portfolio features both RAS(ON) inhibitors, which are designed for potential use as single agents, in conjunct...
Where does RVMDW trade?
Revolution Medicines, Inc. Warrant (RVMDW) trades on the NASDAQ Global Select.
What sector is RVMDW in?
Revolution Medicines, Inc. Warrant (RVMDW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Revolution Medicines, Inc. Warrant?
Mark A. Goldsmith is the chief executive officer of Revolution Medicines, Inc. Warrant (RVMDW).
Where is Revolution Medicines, Inc. Warrant headquartered?
Revolution Medicines, Inc. Warrant is headquartered in United States.
Does RVMDW pay a dividend?
Revolution Medicines, Inc. Warrant (RVMDW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RVMDW go public?
Revolution Medicines, Inc. Warrant (RVMDW) completed its initial public offering in 2020.